Artesunate (AS) oral

Therapeutic action

• Antimalarial

Indications

• Treatment of uncomplicated falciparum malaria, in combination with another antimalarial
• Treatment of uncomplicated malaria due to other Plasmodium species, in combination with another antimalarial, when chloroquine cannot be used
• Completion treatment following parenteral therapy for severe malaria, in combination with another antimalarial

Forms and strengths

• 50 mg tablet

Dosage and duration

• Child and adult: 4 mg/kg once daily for 3 days in combination with another antimalarial

Contra-indications, adverse effects, precautions

• May cause:gastrointestinal disturbances, dizziness.
• Pregnancy: no contra-indication
• Breast-feeding: no contra-indication

Storage

–Below 25 °C